Companies → Grünenthal Österreich GmbH
Save to list
Remove

Grünenthal Österreich GmbH

Austria, Wien
Description
by AI
Grünenthal Österreich GmbH is part of the Grünenthal Group , a global, family-owned pharmaceutical company headquartered in Aachen, Germany. Guided by its purpose of improving lives, Grüenthal concentrates on providing innovative pain management, rare diseases and skin conditions treatments and services to patients with severe diseases and unmet medical needs. Its R&D strategy is focusing on selected fields of expertise, with the aim of discovering new molecules. Consistent with its tradition, Grünenthal invests the majority of its revenues in research and development. The products in this area largely stem from internal research. Transforming from a German family business into a global company required establishing efficient Structures and processes, both in the main German office and in its affiliates around the globe. That meant, above all, creating a new organizational structure and defining clear responsibilities. Worldwide, about 5,200 employees work for Grünenthal in more than 30 countries. Our vision is a world without pain, so we can Improve lives every single day.
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.